Oral Wegovy fell to about 173,500 weekly prescriptions and Foundayo rose to 60,151. Novo also eyes 15 to 20% yearly GLP-1 growth in India.
Recap by typeshit. Post by Investseekers on X.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.
The IMF addresses whether GLP-1 weight loss medications are a safe option for people with myeloma, including those with insulin resistance.
26:51
A full day of low carb, high protein eating from Roseland Lashay as she shifts into maintenance on tirzepatide.
Loading…